For Immediate Release

RESEARCHPOINT ADDS KEY EXECUTIVE

AUSTIN, Texas -- October 12, 2004 — ResearchPoint, a full-service contract research organization (CRO) based in Austin, announced today that Robert J. Davis, Pharm.D., has joined the company as Chief Operations Officer. Davis brings over 20 years of drug development experience to ResearchPoint. His background includes senior management positions in the pharmaceutical, CRO, medical device, and biotechnology industries.

"Dr. Davis' diverse background, coupled with his proven track record of success in drug development and in the CRO industry, provides ResearchPoint with a Chief Operational Officer second to none in our industry," said John Farinacci, ResearchPoint President and CEO.

As Executive Vice President of Sensus, a biotech company founded in Austin and subsequently acquired by Pharmacia (Pfizer), Davis was instrumental in the successful registration of Somavert®, a growth hormone receptor antagonist, in the US, Europe and Japan. Davis began his CRO career at Pharmaco (now PPD) where he was Vice President, Anti-infective Drug Development Services, and later Executive Director of Clinical Development. Following his career at Pharmaco, he served as President at BRI (now Quintiles). Additionally, Davis worked in management positions at Parke Davis and Searle. Dr. Davis received his Doctor of Pharmacy degree from the University of Maryland.

Davis has extensive regulatory experience having worked with the FDA, EU and Koseisho in Japan. He has filed INDs, NDAs and requests for orphan designation to all three agencies, and was part of the team to submit the first electronic NDA to the Division of Endocrinology within the FDA. He participated in a group chosen to work with the FDA to write the initial guidelines for developing anti-infective drugs in the United States.

"A critical component in a rapidly growing organization is the experience and cohesiveness of its management team. Bob Davis will enable ResearchPoint to manage this growth and ensure our strong customer service and quality doesn't waiver," said Farinacci.

ResearchPoint combines traditional and electronically-enhanced development services to the pharmaceutical, biotechnology and medical device industry. ResearchPoint technology initiatives have focused on communication and training as aids to accelerate trials while improving their quality. The ResearchPoint continuum model reflects an integration of services, which ensures a seamless process, with flexibility, energy and customer focus.

For more company information, contact Stella Lattatori at slattatori@researchpoint.com, or visit the website, http://www.researchpoint.com.